Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 60 entries
View as:

Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01860222 Org: User:
Start: 01/31/11 End: 12/31/16 Due: 12/31/17

Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04523467 Org: User:
Start: 12/01/20 End: 12/31/23 Due: 12/31/24

Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00822562 Org: User:
Start: 01/31/09 End: 12/31/10 Due: 12/31/11

Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion

Phase: N/A Priority: Normal
NCT ID: NCT00826384 Org: User:
Start: 10/31/08 End: 12/31/10 Due: 12/31/11

A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06902389 Org: User:
Start: 05/07/25 End: 04/07/28 Due: 04/07/29

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00827554 Org: User:
Start: 12/31/08 End: 10/31/11 Due: 10/31/12

Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00820339 Org: User:
Start: 01/31/09 End: 11/30/12 Due: 11/30/13

Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01914289 Org: User:
Start: 01/31/11 End: 04/30/16 Due: 04/30/17

Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04386772 Org: User:
Start: 05/27/20 End: 12/31/22 Due: 12/31/23

The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene

Phase: N/A Priority: Normal
NCT ID: NCT01786980 Org: User:
Start: 10/31/12 End: 12/31/15 Due: 12/31/16

Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT01643447 Org: User:
Start: 05/31/12 End: 04/30/15 Due: 04/30/16

Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00824707 Org: User:
Start: 12/31/08 End: 12/31/10 Due: 12/31/11

Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC

Phase: N/A Priority: Normal
NCT ID: NCT03047603 Org: User:
Start: 05/01/16 End: 03/20/19 Due: 03/20/20

Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion

Phase: N/A Priority: Normal
NCT ID: NCT02728219 Org: User:
Start: 05/31/12 End: 05/31/15 Due: 05/31/16

A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00825474 Org: User:
Start: 08/31/08 End: 08/31/10 Due: 08/31/11

Prospective Randomized Study of Glucocorticoids in the Impact of the Liver Function and the Prognosis After Hepatectomy of HCC

Phase: N/A Priority: Normal
NCT ID: NCT01608945 Org: User:
Start: 04/30/08 End: - Due: -

Targeted Internal Radiation Therapy in Advanced HCC Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02724267 Org: User:
Start: 11/30/12 End: 12/31/15 Due: 12/31/16

Preoperative Pain Control in Liver Surgery Patients

Phase: N/A Priority: Normal
NCT ID: NCT01923948 Org: User:
Start: 05/31/13 End: 12/31/14 Due: 12/31/15

Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02523053 Org: User:
Start: 04/30/16 End: 12/31/18 Due: 12/31/19

Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02724436 Org: User:
Start: 12/31/12 End: 12/31/15 Due: 12/31/16

A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection

Phase: N/A Priority: Normal
NCT ID: NCT00820053 Org: User:
Start: 01/31/09 End: 12/31/10 Due: 12/31/11

Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection

Phase: N/A Priority: Normal
NCT ID: NCT00825669 Org: User:
Start: 12/31/08 End: 12/31/10 Due: 12/31/11

Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00827047 Org: User:
Start: 01/31/09 End: 12/31/12 Due: 12/31/13

Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02586285 Org: User:
Start: 06/30/15 End: 12/31/17 Due: 12/31/18

Prospective Surveillance for Very Early Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03588442 Org: User:
Start: 07/15/18 End: 07/15/23 Due: 07/15/24